Buprecare Multidose 0.3 mg/ml Solution for Injection for Dogs and Cats
Šalis: Didžioji Britanija
kalba: anglų
Šaltinis: HMA (Heads of Medicines Agencies)
Prekės savybės
(SPC)
09-07-2013
Kai kurių šio produkto dokumentų šiuo metu nėra. Galite atsiųsti užklausą mūsų klientų aptarnavimo tarnybai ir mes jums pranešime, kai tik galėsime juos gauti.
Išsiųsti prašmą.
Išsiųsti prašmą.
Veiklioji medžiaga:
buprenorphine hydrochloride 0.32 mg
Prieinama:
Animalcare Limited
ATC kodas:
QN02AE01
Vaisto forma:
Solution for injection
Farmakoterapinė grupė:
buprenorphine
Gydymo sritis:
Cats, Dogs
Leidimo data:
2008-02-15
Prekės savybės
Revised: June 2013
AN. 00507/2012
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats (UK, BE, FR, IE, LU, NL,
ES)
Buprenovet 0.3 mg/ml Solution for Injection for Dogs and Cats (AT, DE)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Each ampoule contains:
Buprenorphine 0.3 mg/ml as buprenorphine hydrochloride.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, colourless solution.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs and cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Dog
Post-operative analgesia.
Potentiation of the sedative effects of centrally-acting agents.
Cat
Post-operative analgesia.
4.3 CONTRAINDICATIONS
The product should not be used pre-operatively for caesarean section (see Section 4.7).
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Revised: June 2013
AN. 00507/2012
Page 2 of 6
Buprenorphine may occasionally cause significant respiratory depression and, as with
other opioid drugs, care should be taken when treating animals with impaired
respiratory function or animals that are receiving drugs that can cause respiratory
depression.
Buprenorphine should be used with caution in animals with impaired liver function,
especially biliary tract disease, as the substance is metabolised by the liver and its
intensity and duration of ac
Perskaitykite visą dokumentą
